Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 250

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

1,184.50p
   
  • Change Today:
    -17.50p
  • 52 Week High: 1,989.00
  • 52 Week Low: 855.60
  • Currency: UK Pounds
  • Shares Issued: 240.87m
  • Volume: 297,863
  • Market Cap: £2,853.07m
  • RiskGrade: 246

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
19-Mar-18 Barclays Underweight 1,102.00p - - Reiteration
15-Mar-18 Citigroup Buy 1,105.00p - 1,250.00p Upgrade
15-Mar-18 JP Morgan Cazenove Neutral 1,105.00p 1,000.00p 1,050.00p Reiteration
14-Mar-18 Numis Buy 929.00p 1,300.00p 1,300.00p New Coverage
10-Jan-18 Jefferies Underperform 1,009.00p 1,074.00p 895.00p DownGrade
22-Aug-17 Goldman Sachs Neutral 1,188.00p 2,600.00p 1,310.00p DownGrade
11-Aug-17 Numis Securities Add 1,286.00p - 1,560.00p Reiteration
02-Aug-17 Morgan Stanley Equal-weight 1,413.00p 2,050.00p 1,600.00p DownGrade
27-Jun-17 HSBC Reduce 1,516.00p 1,700.00p 1,410.00p Reiteration
25-Jan-17 Peel Hunt Limited Buy 1,863.00p - 2,340.00p Reiteration
16-Mar-16 Panmure Gordon Buy 1,815.00p - 2,120.00p Upgrade

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

HIK Market Data

Currency UK Pounds
Share Price 1,184.50p
Change Today -17.50p
% Change -1.46 %
52 Week High 1,989.00
52 Week Low 855.60
Volume 297,863
Shares Issued 240.87m
Market Cap £2,853.07m
RiskGrade 246

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.1% below the market average17.1% below the market average17.1% below the market average17.1% below the market average17.1% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
51.12% below the market average51.12% below the market average51.12% below the market average51.12% below the market average51.12% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average
Income
44.67% below the market average44.67% below the market average44.67% below the market average44.67% below the market average44.67% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
75.64% below the market average75.64% below the market average75.64% below the market average75.64% below the market average75.64% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 7
Sell 1
Strong Sell 2
Total 14
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 05-Apr-18 24-Aug-17
Paid 24-May-18 22-Sep-17
Amount 23.00¢ 11.00¢

Trades for 19-Apr-2018

Time Volume / Share Price
16:53 804 @ 1,190.72p
16:53 200 @ 1,192.75p
16:53 204 @ 1,195.50p
16:53 318 @ 1,191.35p
16:52 200 @ 1,200.25p

HIK Key Personnel

CFO Khalid Nabilsi
CEO Sigurdur Olafsson

Top of Page